{"nct_id":"NCT04992273","title":"COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2021-09-13","start_date_type":"ACTUAL","primary_completion_date":"2022-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["REGN"]}